Arcturus Therapeutics Holdings Inc. (ARCT) vs Kyverna Therapeutics, Inc. (KYTX)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Kyverna Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.36HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
KYTX
Kyverna Therapeutics, Inc.
$6.31HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — ARCT vs KYTX
growth of $100 · dividends reinvested · last 3yARCT -60.7% (-26.7%/yr)KYTX -78.9% (-40.5%/yr)ARCT compounded faster over this window
ARCT KYTX
ARCT vs KYTX: by the numbers
- •KYTX is the larger company ($384M vs $380M market cap).
- •Both run net losses; KYTX's is the smaller (0.00% vs -391.90% net margin).
Metrics side by side
Valuation
| Metric | ARCT | KYTX |
|---|---|---|
| P/S ratio | 15.95 | N/A |
| P/B ratio | 2.21 | 2.32 |
Profitability
| Metric | ARCT | KYTX |
|---|---|---|
| Gross margin | 95.50% | 0.00% |
| Operating margin | -111.51% | 0.00% |
| Net margin | -391.90% | 0.00% |
| ROE | -54.29% | -92.20% |
| ROIC | -54.07% | -80.67% |
Growth (annualized)
| Metric | ARCT | KYTX |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | N/A |
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEKyverna Therapeutics ROEArcturus Therapeutics operating marginKyverna Therapeutics operating marginArcturus Therapeutics revenue growthKyverna Therapeutics revenue growthArcturus Therapeutics free cash flowKyverna Therapeutics free cash flow
Arcturus Therapeutics & Kyverna Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.